NCS Multistage Holdings, Inc. ( NCSM) Q3 2025 Earnings Call October 30, 2025 8:30 AM EDT Good day, and thank you for standing by. Welcome to the NCS Multistage Q3 2025 Earnings Conference Call.

In addition to its applications in consumer AR, the platform is being qualified for automotive use, fulfilling high automotive quality requirements for robustness and reliability. The display engine ...

NASHVILLE—In Vanderbilt’s biggest defensive performances of 2024, Randon Fontenette was all over the place. He picked off ...

A practical guide to developing a law firm pro bono programme. Through a mixture of commentary, advice, precedents and background information, the manual provides practical help and advice for law ...

A survey of reasoning behaviour in medical large language models uncovers emerging trends, highlights open challenges, and introduces theoretical frameworks that enhance reasoning behaviour ...

The secondary objective is evaluation of efficacy based on the proportion of ... For those unable to listen to the live conference call, a replay will be available for 30 days on the Investors section ...

Eldorado Gold Corporation (TSX: ELD, NYSE: EGO) (“Eldorado” or “the Company”) today reports the Company’s financial and operational results for the third quarter of 2025. For further information, ...

This study introduces Megabouts, a transformer-based classifier for larval zebrafish movement bouts. This useful tool is thoughtfully implemented and has clear potential to unify analyses across labs.

Join WFYI, Ability Allies and The Arc of Indiana for part one of a virtual webinar series on special education on November 13 ...

Third Quarter 2025 Highlights Operations Gold production: 115,190 ounces benefitting from higher production at the Lamaque Complex as a result of accelerated processing of the remaining portion of the ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...

Diabetic complications — the long-term damage to various organ systems — are a great cause of mortality and morbidity in both type 1 and type 2 diabetes. There are currently few therapeutic options to ...